XML 154 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (2,482,111) $ (1,367,513) $ (7,903,394) $ (16,707,010)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 44,428 44,481 177,917 211,720
Change in straight-line rent receivable 29,288 20,548 46,607 10,496
Amortization of operating lease right-of-use asset 18,956 29,448 122,553 118,226
Stock-based compensation and service expense 26,371 45,746 521,509 1,179,761
Income from equity method investment (392,677) (107,469) 846,588 8,589,822
Distribution of earnings from equity method investment 160,788 611,888
Impairment of equity method investment - Epicon     454,679
Amortization of debt issuance costs and debt discount 313,562 272,196 1,411,042 544,010
Change in fair market value of derivative liability 114,360 (31,212) (374,365) (188,374)
Impairment of laboratory equipment     111,033
Debt modification charge     688,794
Gain on debts extinguishment     (682,979)
Changes in operating assets and liabilities:        
Rent receivable 113,024 130,739 (46,220)
Security deposit 5,473 396
Deferred leasing costs 8,021 8,350 33,402 33,402
Prepaid expense and other assets (24,698) (3,739) (91,496) 411
Accrued liabilities and other payables 556,057 (14,758) (1,165,418) (16,601)
Accrued liabilities and other payables - related parties (62,151) (14,051) 106,458
Operating lease obligation (18,956) (23,448) (122,553) (112,915)
NET CASH USED IN OPERATING ACTIVITIES (1,801,926) (915,709) (4,969,205) (6,504,718)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of property and equipment     (22,159)
Payment for equity interest purchase     (100,000)
Proceeds from sale of equity method investment 95,000    
NET CASH PROVIDED BY INVESTING ACTIVITIES 95,000 (100,000) (22,159)
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from loan payable - related party     850,000
Repayments of loan payable - related party     (400,000)
Proceeds from issuance of convertible debts and warrants     3,367,750 2,565,000
Payments of convertible debts issuance costs     (282,700) (327,200)
Proceeds from issuance of convertible debt and warrants 665,000    
Payments of convertible debt issuance costs (72,700)    
Repayments of convertible debt (866,000) (3,388,222) (300,000)
Proceeds from issuance of balloon promissory note     1,000,000
Payments of balloon promissory note issuance costs     (64,436)
Advance from pending sale of noncontrolling interest in subsidiary 219,972 1,210,472 2,122,392 485,714
Proceeds from equity offering     2,857,852 635,391
Disbursements for equity offering costs     (138,405) (19,132)
Proceeds from issuance of convertible preferred stock     3,500,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 219,972 936,772 7,638,667 4,825,337
EFFECT OF EXCHANGE RATE ON CASH 231 (995) 1,447 (3,970)
NET (DECREASE) INCREASE IN CASH (1,486,723) 20,068 2,570,909 (1,705,510)
CASH - beginning of period 2,856,309 285,400 285,400 1,990,910
CASH - end of period 1,369,586 305,468 2,856,309 285,400
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest 164,500 238,782 1,088,512 718,753
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Common stock issued for future services 51,635    
Common stock issued for accrued liabilities 42,385 60,000 164,871
Receivable related to sale of equity method investment 1,745,000    
Related party payable extinguished upon sale of equity method investment 632,916    
Series B Convertible Preferred Stock extinguished related to sale of equity method investment 11,000,000    
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock 9,000,000    
Reclassification of advances for equity interest purchase to equity method investment     9,000,000
Series B Convertible Preferred Stock issued related to equity method investment     11,000,000
Accrued purchase price related to equity method investment     666,667
Warrants issued as convertible note payable finder’s fee 1,679 40,900 16,977
Warrants issued with convertible note payable recorded as debt discount 20,374    
Common stock issued as convertible note payable commitment fee 42,000    
Warrants issued with convertible notes payable recorded as debt discount     438,568 196,193
Common stock issued as convertible notes payable commitment fee     320,546 236,400
Deferred financing costs in accrued liabilities     202,892
Equity method investment payable paid by a related party 666,667 566,667
Reclassification of deferred offering costs     175,136
Settlement of derivative liability 18,853 2,354
Reclassification of related party loan payable and accrued expenses to advance from related party     500,000
Issuance of common stock upon cashless exercise of stock warrants 19 4
Initial ROU asset and lease liability $ 127,486    
Shares issued for adjustments for 1:15 reverse split     $ 21